Hims & Hers Health, Inc. Stock 12‑Month Price Target Raised to $32.23, Implies 1% Upside

Hims & Hers Health, Inc.'s average 12-month price target has been raised from $29.77 to $32.23 by 13 analysts, implying a 1% potential upside based on its closing price. The consensus rating for the stock remains "Hold" among 18 analysts, with a mix of Buy, Hold, and Sell recommendations. Investors can find more detailed price target data and analyst recommendations on the Forecasts tab and News Flow sections of TradingView.